Literature DB >> 34342281

Structural studies of complexes of kallikrein 4 with wild-type and mutated forms of the Kunitz-type inhibitor BbKI.

Mi Li1, Jaroslav Srp2, Michael Mareš2, Alexander Wlodawer1, Alla Gustchina1.   

Abstract

Structures of BbKI, a recombinant Kunitz-type serine protease inhibitor from Bauhinia bauhinioides, complexed with human kallikrein 4 (KLK4) were determined at medium-to-high resolution in four crystal forms (space groups P3121, P6522, P21 and P61). Although the fold of the protein was virtually identical in all of the crystals, some significant differences were observed in the conformation of Arg64 of BbKI, the residue that occupies the S1 pocket in KLK4. Whereas this residue exhibited two orientations in the highest resolution structure (P3121), making either a canonical trypsin-like interaction with Asp189 of KLK4 or an alternate interaction, only a single alternate orientation was observed in the other three structures. A neighboring disulfide, Cys191-Cys220, was partially or fully broken in all KLK4 structures. Four variants of BbKI in which Arg64 was replaced by Met, Phe, Ala and Asp were expressed and crystallized, and their structures were determined in complex with KLK4. Structures of the Phe and Met variants complexed with bovine trypsin and of the Phe variant complexed with α-chymotrypsin were also determined. Although the inhibitory potency of these variant forms of BbKI was lowered by up to four orders of magnitude, only small changes were seen in the vicinity of the mutated residues. Therefore, a totality of subtle differences in KLK4-BbKI interactions within the fully extended interface in the structures of these variants might be responsible for the observed effect. Screening of the BbKI variants against a panel of serine proteases revealed an altered pattern of inhibitory specificity, which was shifted towards that of chymotrypsin-like proteases for the hydrophobic Phe and Met P1 substitutions. This work reports the first structures of plant Kunitz inhibitors with S1-family serine proteases other than trypsin, as well as new insights into the specificity of inhibition of medically relevant kallikreins.

Entities:  

Keywords:  Bauhinia bauhinioides; BbKI; chymotrypsin; human kallikrein 4; kallikreins; plant Kunitz inhibitors; proteases; protein–protein interactions; trypsin

Mesh:

Substances:

Year:  2021        PMID: 34342281      PMCID: PMC8329858          DOI: 10.1107/S2059798321006483

Source DB:  PubMed          Journal:  Acta Crystallogr D Struct Biol        ISSN: 2059-7983            Impact factor:   5.699


  47 in total

1.  Profiling system for skin kallikrein proteolysis applied in gene-deficient mouse models.

Authors:  Martin Horn; Olga Zbodakova; Petr Kasparek; Jaroslav Srp; Radka Haneckova; Martin Hradilek; Michael Mares; Radislav Sedlacek
Journal:  Biol Chem       Date:  2018-09-25       Impact factor: 3.915

Review 2.  Unleashing the therapeutic potential of human kallikrein-related serine proteases.

Authors:  Ioannis Prassas; Azza Eissa; Gennadiy Poda; Eleftherios P Diamandis
Journal:  Nat Rev Drug Discov       Date:  2015-02-20       Impact factor: 84.694

Review 3.  A novel subclassification for Kunitz proteinase inhibitors from leguminous seeds.

Authors:  Maria Luiza V Oliva; Mariana C C Silva; Roberto C Sallai; Marlon V Brito; Misako U Sampaio
Journal:  Biochimie       Date:  2010-04-02       Impact factor: 4.079

Review 4.  Kallikrein-related peptidases targeted therapies in prostate cancer: perspectives and challenges.

Authors:  Vittore Cereda; Vincenzo Formica; Antonello Menghi; Stefania Pellicori; Mario Roselli
Journal:  Expert Opin Investig Drugs       Date:  2015-04-09       Impact factor: 6.206

5.  Bauhinia bauhinioides plasma kallikrein inhibitor: interaction with synthetic peptides and fluorogenic peptide substrates related to the reactive site sequence.

Authors:  M L Oliva; C R Mendes; E M Santomauro-Vaz; M A Juliano; R Mentele; E A Auerswald; M U Sampaio; C A Sampaio
Journal:  Curr Med Chem       Date:  2001-07       Impact factor: 4.530

6.  Features and development of Coot.

Authors:  P Emsley; B Lohkamp; W G Scott; K Cowtan
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2010-03-24

7.  Blocking the proliferation of human tumor cell lines by peptidase inhibitors from Bauhinia seeds.

Authors:  Adriana Miti Nakahata; Barbara Mayer; Peter Neth; Daiane Hansen; Misako Uemura Sampaio; Maria Luiza Vilela Oliva
Journal:  Planta Med       Date:  2013-01-23       Impact factor: 3.352

8.  Chymotryptic specificity determinants in the 1.0 A structure of the zinc-inhibited human tissue kallikrein 7.

Authors:  Mekdes Debela; Petra Hess; Viktor Magdolen; Norman M Schechter; Thomas Steiner; Robert Huber; Wolfram Bode; Peter Goettig
Journal:  Proc Natl Acad Sci U S A       Date:  2007-10-01       Impact factor: 11.205

9.  Overview of the CCP4 suite and current developments.

Authors:  Martyn D Winn; Charles C Ballard; Kevin D Cowtan; Eleanor J Dodson; Paul Emsley; Phil R Evans; Ronan M Keegan; Eugene B Krissinel; Andrew G W Leslie; Airlie McCoy; Stuart J McNicholas; Garib N Murshudov; Navraj S Pannu; Elizabeth A Potterton; Harold R Powell; Randy J Read; Alexei Vagin; Keith S Wilson
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2011-03-18

10.  MolProbity: all-atom structure validation for macromolecular crystallography.

Authors:  Vincent B Chen; W Bryan Arendall; Jeffrey J Headd; Daniel A Keedy; Robert M Immormino; Gary J Kapral; Laura W Murray; Jane S Richardson; David C Richardson
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2009-12-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.